Free Trial
NYSE:SOLV

Solventum (SOLV) Stock Price, News & Analysis

Solventum logo
$73.00 -0.68 (-0.92%)
Closing price 03:59 PM Eastern
Extended Trading
$71.88 -1.13 (-1.54%)
As of 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Solventum Stock (NYSE:SOLV)

Key Stats

Today's Range
$71.98
$73.75
50-Day Range
$65.57
$78.21
52-Week Range
$47.16
$85.92
Volume
530,918 shs
Average Volume
1.11 million shs
Market Capitalization
$12.63 billion
P/E Ratio
33.80
Dividend Yield
N/A
Price Target
$84.38
Consensus Rating
Hold

Company Overview

Solventum Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

SOLV MarketRank™: 

Solventum scored higher than 15% of companies evaluated by MarketBeat, and ranked 873rd out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Solventum has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 6 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Solventum has only been the subject of 4 research reports in the past 90 days.

  • Read more about Solventum's stock forecast and price target.
  • Earnings Growth

    Earnings for Solventum are expected to decrease by -16.57% in the coming year, from $6.58 to $5.49 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Solventum is 33.80, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.70.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Solventum is 33.80, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.61.

  • Price to Earnings Growth Ratio

    Solventum has a PEG Ratio of 1.90. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Solventum has a P/B Ratio of 4.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Solventum's valuation and earnings.
  • Percentage of Shares Shorted

    3.18% of the float of Solventum has been sold short.
  • Short Interest Ratio / Days to Cover

    Solventum has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Solventum has recently increased by 4.76%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Solventum does not currently pay a dividend.

  • Dividend Growth

    Solventum does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.18% of the float of Solventum has been sold short.
  • Short Interest Ratio / Days to Cover

    Solventum has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Solventum has recently increased by 4.76%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Solventum has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Solventum this week, compared to 12 articles on an average week.
  • Search Interest

    7 people have searched for SOLV on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
Receive SOLV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter.

SOLV Stock News Headlines

Morgan Stanley Upgrades Solventum (SOLV)
Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway
Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!
See More Headlines

SOLV Stock Analysis - Frequently Asked Questions

Solventum's stock was trading at $66.06 at the beginning of the year. Since then, SOLV shares have increased by 10.6% and is now trading at $73.0650.

Solventum Corporation (NYSE:SOLV) released its quarterly earnings results on Thursday, May, 8th. The company reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.15. The business's revenue for the quarter was up 2.7% compared to the same quarter last year.
Read the conference call transcript
.

Solventum's top institutional shareholders include Assenagon Asset Management S.A. (0.33%), Wedge Capital Management L L P NC (0.24%), Kingstone Capital Partners Texas LLC (0.10%) and Farmers Trust Co. (0.04%).

Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/08/2025
Today
7/16/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NYSE:SOLV
Previous Symbol
NYSE:SOLV
CIK
1964738
Fax
N/A
Employees
22,000
Year Founded
N/A

Price Target and Rating

High Price Target
$103.00
Low Price Target
$71.00
Potential Upside/Downside
+16.1%
Consensus Rating
Hold
Rating Score (0-4)
2.27
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.16
Trailing P/E Ratio
33.63
Forward P/E Ratio
11.04
P/E Growth
1.9
Net Income
$478 million
Net Margins
4.55%
Pretax Margin
3.78%
Return on Equity
31.01%
Return on Assets
6.53%

Debt

Debt-to-Equity Ratio
2.40
Current Ratio
1.19
Quick Ratio
0.85

Sales & Book Value

Annual Sales
$8.31 billion
Price / Sales
1.51
Cash Flow
$9.75 per share
Price / Cash Flow
7.45
Book Value
$17.13 per share
Price / Book
4.24

Miscellaneous

Outstanding Shares
173,013,000
Free Float
172,926,000
Market Cap
$12.57 billion
Optionable
Optionable
Beta
0.55
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:SOLV) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners